Search

23 Feb 2024: lupus erythematosus</li> <li>autoimmune diseases</li> <li>atherosclerosis</li> <li>immunotherapy</li> <li>glomerular disease</li> <li>chronic inflammation</li> <li>vasculitis</li> <li>Wegener's granulomatosis</li> <li>ANCA

23 Feb 2024: Search site. Cambridge Immunology Network. Professor Ken Smith. Ken Smith established the Cambridge Immunology Strategic Research Network, which unifies both basic and translational immunological research across the broader Cambridge area. He also

23 Feb 2024: Copy number of FCGR3B, which is associated with systemic lupus erythematosus, correlates with protein expression and immune complex uptake.

23 Feb 2024: I have recently showed that in lupus nephritis, autoreactive plasma cells mostly home and survive in the inflamed kidneys, suggesting that the renal plasma cell niche may constitute a new therapeutic ... Local renal autoantibody production in lupus

23 Feb 2024: Takayasu’s arteritis. Cryogobulinaemia. Henoch-Schonlein purpura. Lupus (SLE). Behcet’s disease. Autoimmune deafness. ... A defunctioning polymorphism in FCGR2B is associated with protection against malaria but susceptibility to systemic lupus

23 Feb 2024: Novel expression signatures identified by transcriptional analysis of separated leucocyte subsets in systemic lupus erythematosus and vasculitis.

19 Feb 2024: the University of Cambridge to study the experiences of patients with lupus and related diseases. ... of Cambridge to study the experiences of patients with lupus and related diseases.

23 Feb 2024: Search site. Cambridge Immunology Network. Browse for people by keyword. Contact us. Cambridge Immunology Network Coordinator. University of Cambridge Department of Medicine,. Jeffrey Cheah Biomedical Centre,. Cambridge Biomedical Campus, Puddicombe

19 Feb 2024: ll448 Mon, 14 Dec 2020 16:24:36 0000 Behavioural Science Group Featured News PCU Updates Research News COVID-19 lupus LUPUS UK Melanie Sloan ... management of systemic lupus erythematosus./h4 h4She said: “There is no doubt that these serious and

23 Feb 2024: Cambridge Immunology Network - Transplantation https://www.immunology.cam.ac.uk/Networkdirectory/research-themes/transplantation Understanding and minimising transplant rejection Organ transplantation involves the transfer of an organ from one

23 Feb 2024: lupus erythematosus</li> <li>autoimmune diseases</li> <li>atherosclerosis</li> <li>immunotherapy</li> <li>glomerular disease</li> <li>chronic inflammation</li> <li>vasculitis</li> <li>Wegener's granulomatosis</li> <li>ANCA

23 Feb 2024: lupus erythematosus</li> <li>autoimmune diseases</li> <li>atherosclerosis</li> <li>immunotherapy</li> <li>glomerular disease</li> <li>chronic inflammation</li> <li>vasculitis</li> <li>Wegener's granulomatosis</li> <li>ANCA

23 Feb 2024: lupus erythematosus</li> <li>autoimmune diseases</li> <li>atherosclerosis</li> <li>immunotherapy</li> <li>glomerular disease</li> <li>chronic inflammation</li> <li>vasculitis</li> <li>Wegener's granulomatosis</li> <li>ANCA

23 Feb 2024: The consortia funded in this round cover a spectrum of diseases from the rare condition Systemic Lupus Erythematosus to more common conditions affecting millions of patients. ... Funded by the MRC (c£4.2m). The MASTERPLANS consortium will ‘stratify’

23 Feb 2024: lupus erythematosus</li> <li>autoimmune diseases</li> <li>atherosclerosis</li> <li>immunotherapy</li> <li>glomerular disease</li> <li>chronic inflammation</li> <li>vasculitis</li> <li>Wegener's granulomatosis</li> <li>ANCA

23 Feb 2024: lupus erythematosus</li> <li>autoimmune diseases</li> <li>atherosclerosis</li> <li>immunotherapy</li> <li>glomerular disease</li> <li>chronic inflammation</li> <li>vasculitis</li> <li>Wegener's granulomatosis</li> <li>ANCA

21 Jul 2023: Other antibodies followed, including BENLYSTA, which promises to be the first new drug treatment for systemic lupus erythematosus (SLE) in 50 years and Abthrax, against infectious anthrax, which has been stockpiled

23 Feb 2024: lupus erythematosus</li> <li>autoimmune diseases</li> <li>atherosclerosis</li> <li>immunotherapy</li> <li>glomerular disease</li> <li>chronic inflammation</li> <li>vasculitis</li> <li>Wegener's granulomatosis</li> <li>ANCA

19 Feb 2024: of Cambridge to study the experiences of patients with lupus and related diseases. ... News COVID-19 lupus LUPUS UK Melanie Sloan https://www.phpc.cam.ac.uk/pcu/?p=21900 During the 2020 pandemic, patients with systemic autoimmune rheumatic diseases

23 Feb 2024: lupus erythematosus</li> <li>autoimmune diseases</li> <li>atherosclerosis</li> <li>immunotherapy</li> <li>glomerular disease</li> <li>chronic inflammation</li> <li>vasculitis</li> <li>Wegener's granulomatosis</li> <li>ANCA